| TNBS | 2,4,6-trinitrobenzenesulfonic acid |
| 5-HT | 5-hydroxytryptamine |
| ACF | Aberrant crypt foci |
| ATF3/4 | Activating transcription factor 3, 4 |
| APC | Adenomatous polyposis coli |
| A2A | Adenosine receptor 2A |
| MAPK | Amitogen-activated protein kinase |
| AOM/DSS | Azoxymethane/dextran sodium sulfate |
| CBD | Cannabidiol |
| CBD-BDSs | Cannabidiol botanical drug substances |
| CB1 and CB2 | Cannabinoid receptor 1 and 2 |
| CHOP | C/EBP homologous protein |
| CNS | Central nervous system |
| CRC | Colorectal cancer |
| CDK2/4/6 | Cyclin-dependent kinase 2, 4, 6 |
| COX-2 | Cyclo-oxygenase-2 |
| DR5 | Death receptor 5 |
| THC | D9-tetrahydrocannabinol |
| ECs | Enterochromaffin cells |
| EMT | Epithelial–mesenchymal transition |
| GPR55 | G-protein-coupled receptor 55 |
| GABAA | γ-aminobutyric acid type A receptor |
| GI | Gastrointestinal tract |
| GPx | Glutathione peroxidase |
| GR | Glutathione reductase |
| HIF-1α | Hypoxia-induced factor-1α |
| BiP | Immunoglobulin protein |
| IRE1α | Inositol-requiring enzyme 1α |
| NO | Nitric oxide |
| NOS3 | Nitric oxide synthase 3 |
| PPARγ | Peroxisome proliferator-activated receptor-gamma |
| eIF2α | Phosphorylated eukaryotic initiation factor 2α |
| PERK | Phosphorylated protein kinase RNA-like ER kinase |
| ROS | Reactive oxygen species |
| SSRIs | Serotonin reuptake inhibitors |
| SERTs | Serotonin transporters |
| SCFAs | Short-chain fatty acids |
| SOD | Superoxide dismutase |
| TGF-β | Transforming growth factor beta |
| TRPV | Transient receptor potential cation channel subfamily V |
| TPH | Tryptophan hydroxylase |
| VEGF | Vascular endothelial growth factor |